Suppr超能文献

基于谷氨酸的二肽的合成与抗增殖活性

Synthesis and antiproliferative activity of glutamic acid-based dipeptides.

作者信息

Silveira-Dorta Gastón, Martín Víctor S, Padrón José M

机构信息

BioLab, Instituto Universitario de Bio-Orgánica "Antonio González" (IUBO-AG), Centro de Investigaciones Biomédicas de Canarias (CIBICAN), Universidad de La Laguna, C/Astrofísico Francisco Sánchez 2, 38206, La Laguna, Spain.

出版信息

Amino Acids. 2015 Aug;47(8):1527-32. doi: 10.1007/s00726-015-1987-0. Epub 2015 Apr 22.

Abstract

A small and focused library of 22 dipeptides derived from N,N-dibenzylglutamic acid α- and γ-benzyl esters was prepared in a straightforward manner. The evaluation of the antiproliferative activity in the human solid tumor cell lines HBL-100 (breast), HeLa (cervix), SW1573 (non-small cell lung), T-47D (breast), and WiDr (colon) provided γ-glutamyl methionine (GI50 = 6.0-41 μM) and α-glutamyl proline (GI50 = 7.5-18 μM) as lead compounds. In particular, glutamyl serine and glutamyl proline dipeptides were more active in the resistant cancer cell line WiDr than the conventional anticancer drugs cisplatin and etoposide. Glutamyl tryptophan dipeptides did not affect cell growth of HBL-100, while in T-47D cells, proliferation was inhibited. This result might be attributed to the inhibition of the ATB(0,+) transporter.

摘要

以一种直接的方式制备了一个由22种源自N,N-二苄基谷氨酸α-和γ-苄酯的二肽组成的小型且有针对性的文库。对人实体瘤细胞系HBL-100(乳腺)、HeLa(宫颈)、SW1573(非小细胞肺癌)、T-47D(乳腺)和WiDr(结肠)的抗增殖活性评估表明,γ-谷氨酰甲硫氨酸(GI50 = 6.0 - 41 μM)和α-谷氨酰脯氨酸(GI50 = 7.5 - 18 μM)为先导化合物。特别是,谷氨酰丝氨酸和谷氨酰脯氨酸二肽在耐药癌细胞系WiDr中比传统抗癌药物顺铂和依托泊苷更具活性。谷氨酰色氨酸二肽不影响HBL-100的细胞生长,而在T-47D细胞中,增殖受到抑制。该结果可能归因于对ATB(0,+)转运体的抑制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验